BYU and Pfizer reach settlement

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Brigham Young University and the pharmaceutical company Pfizer have reached a settlement.

BYU sought roughly $10 billion, claiming Pfizer took research done by BYU’s doctor Daniel Simmons toward production of the pain drug Celebrex.

On Tuesday morning, Pfizer released a statement regarding the pending case saying they reached a settlement with BYU.  In the statement, Pfizer said the agreement was “amicable and on confidential terms.”

As part of the resolution, a Dan Simmons chair will be established at BYU in Recognition of Dr. Simmon’s work and contributions to the field of medicine.

A BYU spokesperson confirmed the settlement saying they are very pleased with the outcome.

Related: BYU in $10B civil suit with Pfizer